Diary / Calendar Diary/Calendar

Medicine Department

  2. Faculty
  3. Dr. Simmi Dube
Dr. SIMMI DUBE

Dr. Simmi Dube

  • Designation: Professor & HOD
  • Qualification: MD-MEDICINE
  • Medical Council Registration: MP-10965
  • About Faculty: Dr. Simmi Dube
  • Education and Qualification:

     

     Qualification/Degree  Date  College  University
     MBBS  1990  GMC BHOPAL  BARKATULLAH UNIVERSITY BHOPAL
     MD-GENERAL MEDICINE  1994  GMC BHOPAL  BARKATULLAH UNIVERSITY BHOPAL
    Visiting Scientist (3 years) at Department of Endocrinology Diabetes, Metabolism & Nutrition Mayo Clinic Rochester, MN USA
    Fellow of World Health Organization on POISON MANAGEMENT
    Fellow of Indian College of Physicians
    Fellow of Indian Society of Electrocardiology
    Fellow of Research Society for Study of Diabetes in India
  • Work Experience:

     

     Post  Institution  From To  Total Years
    As Demonstrator/Tutor GMC Bhopal 05/10/1994    04/10/1996  2 Year 
    As Assistant Professor GMC Bhopal 25/04/1998   12/07/2005  7 Year 2 Month
    As Associate Professor GMC Bhopal 12/07/2005    23/03/2018 12 Year 8 Month
    As Professor GMC Bhopal 23/03/2018   Till Date  6 Year 4 Month
    Grand Total of Teaching Experience 28 Year 2 Month 
    Detail of service/Working - working place/Institute name
     2016 Gandhi Medical College Bhopal
    2017 Gandhi Medical College Bhopal
    2018 Gandhi Medical College Bhopal
    2019 Gandhi Medical College Bhopal
    2020 Gandhi Medical College Bhopal
    2021 Gandhi Medical College Bhopal
  • Publications:

     

    Publications
      1   Gondane B, Jain SK, Dube S, etal.Clinical Profile of Mucormycosis Patients during CoronavirusDisease 2019 Pandemic: A Retrospective Observational Study. J Assoc Physicians India 2024;;72(3):27–31
    2

    Rizwan SA, Ponnaiah, Dube S, et al. Baseline findings of a multicentric ambispective cohort study (2021-2022) among hospitalised mucormycosis patients in India. Mycology 2024 Jan 17;15(1):70-84.https://doi.org/10.1080/21501203.2023.2271928 (Principal Investigator - GMC Bhopal Site)
    3 Kumar G, Talukdar A, Turuk A, Dube S, NCRC team. Determinants of post discharge mortality among hospitalized COVID-19 patients.Indian J Med Res. 2023;158(2):136-144. (Principal Investigator - GMC Bhopal Site)
    4 Verma S, Sejwar A, Dube S, etal. Correlation of Clinical Parameters with Findings of Highresolution Computed Tomography Chest in COVID-19 Patients. J Assoc Physicians India Nov 2023;71(11):25–29
    5 Kumar G,Bhalla A, Dube S, & National Clinical Registry for COVID-19 Team.Post COVID sequelae among COVID-19 survivors: insights from the Indian National Clinical Registry for COVID-19.BMJ Glob Health 2023 Oct;8(10):e012245. (Principal Investigator - GMC Bhopal Site)
    6

    Kajal K,Singla K, Dube S, & National Clinical Registry for COVID-19 Team. Analysis of Predictors and Outcomes of COVID-19 Patients Requiring ICU Admission from COVID-19 Registry, India. Indian J Crit Care Med. 2023 Aug; 27(8): 552–562. (Principal Investigator - GMC Bhopal Site)
     

    Turuk A, Kumar G, Dube S& National Clinical Registry for COVID-19 Team. Evaluation of a Hospitalized Pediatric COVID-19 Cohort from Indian National Clinical Registry of COVID-19. Indian J Pediatr. 2023;90 (10):1000-1007. (Principal Investigator - GMC Bhopal Site)
    8 Mukherjee A, Dube S& National Clinical Registry for COVID-19 Team.Vaccination saves lives: a real-time study of patients with chronic diseases and severe COVID-19 infection. QJM. 2023 Feb 14;116(1):47-56.(Principal Investigator - GMC Bhopal Site)
    9 Ponnaiah M, Dube S,et al.Hyperglycemia and steroid use increase the risk of rhino-orbito-cerebral mucormycosis regardless of COVID-19 hospitalization: Case-control study, India.PLoS One. 2022 Aug 8;17(8):e0272042.(Principal Investigator - GMC Bhopal Site)
    10

    Zodpey SP, Dube S, etal.Determinants of severity among hospitalised COVID-19 patients: Hospital-based case-control study, India, 2020.PLoS One 2021 Dec 29;16(12): e0261529 (Principal Investigator - GMC Bhopal Site)
    11 Mammen JJ, Dube S, et al.Factors associated with mortality among moderate and severe patients with COVID-19 in India: a secondary analysis of a randomised controlled trial.Randomized Controlled Trial BMJ Open, 2021 Oct 4;11(10):e050571.(Principal Investigator - GMC Bhopal Site)
    12 Kumar G, Dube S& National Clinical Registry for COVID-19 Team. Clinical profile of hospitalized COVID-19 patients in first & second wave of the pandemic: Insights from an Indian registry based observational study. Indian J Med Res. 2021 May;153(5&6):619-628. (Principal Investigator - GMC Bhopal Site)
    13

    Dube S, PLACID Trial Collaborators. Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)-CTRI/2020/04/024775. BMJ. 2020; 371: m3939. (Principal Investigator - GMC Bhopal Site)
    14 Mishra T, Dave L,Kawre KK, Dube S. Pulmonary Functions in People with Type 2 Diabetes Mellitus. Journal of Association of Physicians of India. 2021;69:66-69. (Corresponding Author)
    15

    Jain SK, Dudani A, Jaiswal N,Deopujari K, Dube S.Assessment of Clinical Profile & Risk Factors Associated with Adverse Outcome in COVID-19 Patients at a Tertiary Care Hospital in Central India- A Retrospective Record Based Study. JAssoc Physicians India.April 2021;69:27-31(Corresponding Author)
    16 Jain SK, Banerjee S, Rai V,Bansal M, Kawre KK, Dube S. Spectrum Of Cardiac Complications In Covid 19 Deaths- A Retrospective Case Record Analysis At A Dedicated Covid Care Hospital In Central India.International Journal of Scientific research. 2021;10 (03): 70-71 (Corresponding Author)
    17

    Patidar L, Jain SK, Kawre KK, Dube S. Serum Amylase and serum Lipase in Diabetic Ketoacidosis.Global journal of Research Analysis.2020;09(06):1-3(Corresponding Author)
    18  Errazuriz I, Dube S, Slama M, Visentin R, Nayar S, O'Connor H, Cobelli C, Das SK, Basu A, Kremers WK, Port J, Basu R. Randomized Controlled Trial of a MUFA or Fiber-rich diet on Hepatic fat in Pre-diabetes. J Clin Endocrinol Metab. 2017 May 1;102(5):1765-1774
    19  Dube S, Slama MQ, Basu A, Rizza RA, Basu R. Glucocorticoid excess increases Hepatic 11β-HSD-1 activity in Humans; implications in steroid induced diabetes. J Clin Endocrinol Metab. 2015 Nov;100(11):4155-62
    20 Dube S., Norby B., Pattan, V., Lingineni RK., Singh RJ., Carter RE., Basu A., Basu R. Hepatic 11beta-hydroxysteroid dehydrogenase type 1 activity in obesity and type 2 diabetes using a novel triple tracer cortisol technique. Diabetologia. 2014 Jul;57(7):1446-55.
    21 Dube S, Norby BJ, Pattan V, Carter RE, Basu A, Basu R. 11 β-Hydroxysteroid Dehydrogenase Type 1 and 2 Activity in Subcutaneous Adipose Tissue in Humans: Implications in Obesity and Diabetes. J Clin Endocrinol Metab. 2015 Jan;100(1):E70-6
    22 Basu A, Dube S, Veettil S, Slama M, Kudva Y, Peyser T, Carter R, Cobelli C, Basu R.Time Lag of Glucose from Intravascular to Interstitial Compartment in Type 1 Diabetes. J Diabetes Sci Technol. 2015 Jan;9(1):63-8.
    23 Limberg JK, DubeS, Kuijpers M, Farni KE, Basu A, Rizza RA, Curry TB, Basu R, Joyner MJ. Effect of hypoxia on heart rate variability and baroreflex sensitivity during hypoglycemia in type 1 diabetes mellitus. Clin Auton Res. 2015 Aug;25(4):243-50
    24

    Basu A, Dube S, Slama M, Errazuriz I, Amezcua JC, Kudva YC, Peyser T, Carter RE, Cobelli C, Basu R. Time Lag of Glucose from Intravascular to Interstitial Compartment in Humans. Diabetes. 2013 Dec;62(12):4083-7.
    25 Rajpal A, Dube S, Carvalho F, Simoes AR, Figueiredo A, Basu A, Jones JG, Basu R. Effects of Transaldolase Exchange on Estimates of Gluconeogenesis in Type 2 Diabetes.  Am J Physiol Endocrinol Metab. 2013 Aug;305(4):E465-74
    26 Basu R, Barosa C, Jones J, Dube S, Carter RE, Basu A, Rizza RA. Pathogenesis of prediabetes: role of the liver in isolated fasting hyperglycemia and combined fasting and postprandial hyperglycemia.  J Clin Endocrinol Metab. 2013 Mar;98(3):E409-17
    27 Schiavon M, Dalla Man C, Dube S, Slama M, Kudva YC, Peyser T, Basu A, Basu R, Cobelli C. Modeling Plasma-to-Interstitium Glucose Kinetics from Multitracer Plasma and Microdialysis Data. Diabetes Technol Ther. 2015 Nov;17(11):825-31.
    28

    Limberg JK, Taylor JL, Mozer MT,Dube S Effect of bilateral carotid body resection on cardiac baroreflex control of blood pressure during hypoglycemia.Hypertension 2015 Jun;65(6):1365-71
    29 Wehrwein EA, Limberg JK, Taylor JL, Dube S, Basu A, Basu R, Rizza RA, Curry TB, Joyner MJ. Effect of bilateral carotid body resection on the counterregulatory response to hypoglycemia in humans. Exp Physiol. 2015 Jan 1;100(1):69-78
    30 Limberg JK, Taylor JL, Dube S, Basu R, Basu A, Joyner MJ, Wehrwein EA. Role of the carotid body chemoreceptors in baroreflex control of blood pressure during hypoglycaemia in humans. Exp Physiol. 2014 Apr;99(4):640-50.
    31 Limberg JK, Farni KE, Taylor JL, Dube S, Basu A, Basu R, Wehrwein EA, Joyner MJ. Autonomic control during acute hypoglycemia in type 1 diabetes mellitus. Clin Auton Res. 2014 Dec;24(6):275-83
    32 

    Nahar N, Dube S, Joshi A, Phadnis S, Sharma VK. Association of anthropometric Indices of Obesity with Diabetes,Hypertension and Dyslipidemia:A study from Central India. Indian J Med Spec 2012; 3:6-11
    33  Dube S, Sharma VK, Dubey TN, Mehta A, Gaur D. Screening for impaired fasting glucose and diabetes mellitus among people with major risk factors for type 2 diabetes mellitus. International journal of diabetes in developing countries. June 2007.27:2:35-40.http://rssdi.in/new/diabetesbulletin/2007-april.html
  • Other Details:

     

    Enlist the topic Covered in last one year
    1  Covid- 19 : Introduction and Pathophysiology
    2 Covid management Guidelines : Mild/Moderate and Severe cases
    3 Personal Protective etiquettes and Infection Prevention Practices
    4 Basics of oxygen therapy in management of covid cases
    5 Hemodynamic monitoring, fluids therapy and glycemic control in Covid ICU
    6 First Aid
    7 History taking in medicine,Gen examination
    8 Approach to patient with endocrine diseases
    9 Approach to patient with heamatological diseases
    10 Diabetes mellitus-2diagnosis,classification,management
    11 Recent advances in diabetes management
    12 Diseases of intermediate metabolism
    13 Approach to a patient with obesity
    14 How to write a research proposal and research paper
    15 Newer OHA with recent guidelines for the management of DM
    16 Examination of CVS
    17 Examination of CNS
    18 Examination of GIT
    19 Examination of Respiratory system